BIIB Biogen Inc.
$227.60
Biogen Inc. (BIIB) is expected to report earnings on October 27, 2026, before the market open. The consensus earnings estimate is $2.10 per share, and the stock has had a Post-Earnings Announcement Drift (PEAD) of +8.1% since its last earnings release on July 29, 2026.
Biogen Beat Consensus Estimates
Wednesday, July 29, 2026 · 12:00 AM ET
Earnings Date
3rd Quarter, Sep 2026
Oct 27
Tuesday · Before Open
Earnings Whisper
-
vs $2.10
Rev est $2.59B
Volatility
Enter your expectations below to reveal the current volatility.
Trend Analysis
Expectation
Earnings
Price action
Signals
Score
Sentiment
Grade
Life Cycle
Call Analysis
Earnings-AVWAP
$214.25
Sign in or subscribe to unlock sentiment, short interest, and technical indicators.
Whisperings™
About Biogen Inc.
Biogen Idec Inc, is a biopharmaceutical company. The Company discovers, develops, manufactures and markets therapies for neurological, autoimmune and hematologic disorders.
Sector
Healthcare
Industry
Biotechnology
Held By 15 ETFs, by dollar flow
- XT iShares Exponential Technologies ETF
- XT iShares Exponential Technologies ETF
- QNXT iShares Nasdaq-100 ex Top 30 ETF
- QNXT iShares Nasdaq-100 ex Top 30 ETF
- IYH iShares U.S. Healthcare ETF
- IYH iShares U.S. Healthcare ETF
- XLV Health Care Select Sector SPDR Fund
- XLV Health Care Select Sector SPDR Fund
- IXJ iShares Global Healthcare ETF
- IXJ iShares Global Healthcare ETF
- BMED iShares Health Innovation Active ETF
- BMED iShares Health Innovation Active ETF
- BBH VanEck Biotech ETF
- BBH VanEck Biotech ETF
- IBRN iShares Neuroscience and Healthcare ETF
Charts powered in part by Lightweight Charts™ by TradingView.